No Data
No Data
CorMedix Set for Market Growth With Policy Changes and Strategic Partnerships Boosting DefenCath Adoption
CorMedix Inc. Supports CMS Policy Updates Regarding Access to Innovative Drug Products
CORMEDIX INC. SUPPORTS CMS POLICY UPDATES REGARDING ACCESS TO INNOVATIVE DRUG PRODUCTS
CorMedix Approves Key Governance and Incentive Changes
Here's Why We Think CorMedix Inc.'s (NASDAQ:CRMD) CEO Compensation Looks Fair for the Time Being
CorMedix Inc. to Participate in the Truist Securities BioPharma Symposium
No Data
No Data